Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis

Table 2 Characteristics of study population (Crohn’s disease and ulcerative colitis)

	CD active	CD inactive	UC active	UC inactive	P value
N	81	16	52	22
Age (yr)	35.3 ± 12.7	35.7 ± 10.5	40.9 ± 13.8	39 ± 10.5	0.081
Gender (F/M)	42/39	5/11	21/31	11/11	0.346
Hb (g/dL)	12 ± 1.9	13.8 ± 2.1	12.2 ± 2.4	12.8 ± 1.5	0.028
PLT (× 103/mm3)	397 (297-483)	283 (215-344)	314 (283-434)	264 (226-327)	< 0.001
WBC (× 103/mm3)	7.89 (5.9-10.8)	6.24 (5.5-7.3)	7.91 (6.1-9)	6.2 (5.1-7.6)	0.046
Protein (g/dL)	6.97 ± 0.99	7.26 ± 0.74	6.77 ± 0.88	7.23 ± 0.54	0.152

Data on age, hemoglobin (Hb), and total protein concentration presented as mean ± SD and analyzed using one-way ANOVA; data on platelet (PLT) and leukocyte (WBC) counts presented as medians with interquartile range and analyzed using Kruskal-Wallis H test; data on gender distribution (F-females, M-males) was analyzed using χ² test. CD: Crohn’s disease; UC: Ulcerative colitis.